Ravelcare Ltd
Ravelcare Ltd (RAVEL) last reported results for the quarter ended Mar 2026, with sales of ₹12.56 crore and net profit of ₹1.95 crore. The stock last traded at ₹101, a market capitalisation of ₹69.3 crore, on a P/E of 13.1. Over the past 52 weeks the stock has ranged between ₹96 and ₹215. Figures are as of 6 Oct 2026 and are not real time.
Ravelcare Ltd share price and key metrics
- Current price
- ₹101
- Market cap
- ₹69.3 cr
- Stock P/E
- 13.1
- Book value
- ₹54.5
- ROE
- 22.2%
- ROCE
- 30.5%
- Dividend yield
- 0.00%
- 52w high / low
- 215/96.0
Metrics as of 6 Oct 2026. Not real time.
Track Ravelcare Ltd
Cruxal reads every Ravelcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Ravelcare Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 98%
- TTM
- 8%
- 10 Years
- %
- 5 Years
- 119%
- 3 Years
- 111%
- TTM
- 5%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 45%
- Last Year
- 22%
Ravelcare Ltd quarterly results
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 14.58 | 12.56 |
| Expenses | 13.3 | 9.84 |
| Operating profit | 1.28 | 2.72 |
| OPM % | 8.78% | 21.66% |
| Other income | 0.27 | 0.04 |
| Interest | 0 | 0 |
| Depreciation | 0.05 | 0.03 |
| Profit before tax | 1.5 | 2.73 |
| Tax % | 0.67% | 28.57% |
| Net profit | 1.5 | 1.95 |
| EPS (₹) | 3.00 | 2.84 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Ravelcare Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | — | 0.79 | 3.48 | 22.06 | 24.98 | 26.95 |
| Operating profit | — | -0.21 | 0.51 | 6.71 | 6.82 | 7.07 |
| OPM % | — | -26.58% | 14.66% | 30.42% | 27.30% | 26.23% |
| Net profit | -0.11 | -0.23 | 0.56 | 5.1 | 5.09 | 5.15 |
| EPS (₹) | -220.00 | -460.00 | 1,120.00 | 10,200.00 | 10.17 | 7.51 |
TTM is the trailing twelve months to the most recent quarter.
Ravelcare Ltd balance sheet
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 0.01 | 0.01 | 0.01 | 0.01 | 5.01 | 6.86 |
| Reserves | -0.12 | -0.35 | 0.16 | 5.25 | 5.34 | 30.55 |
| Borrowings | 0.12 | 0.42 | 0.41 | 0.04 | 0.00 | 0.00 |
| Other liabilities | 0.00 | -0.01 | 1.17 | 4.18 | 1.28 | 2.92 |
| Total liabilities | 0.01 | 0.07 | 1.75 | 9.48 | 11.63 | 40.33 |
| Fixed assets | 0.00 | 0.00 | 0.01 | 0.22 | 0.16 | 0.11 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.48 |
| Investments | 0.00 | 0.00 | 0.00 | 0.79 | 3.07 | 4.51 |
| Other assets | 0.01 | 0.07 | 1.74 | 8.47 | 8.40 | 33.23 |
| Total assets | 0.01 | 0.07 | 1.75 | 9.48 | 11.63 | 40.33 |
As reported by the company. Total assets equal total liabilities by construction.
Ravelcare Ltd cash flow
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operations | -0.41 | 1.00 | 6.49 | -3.18 | -17.47 |
| Cash from investing | 0.00 | -0.01 | -6.92 | 3.81 | -4.12 |
| Cash from financing | 0.41 | -0.01 | -0.44 | -0.04 | 21.91 |
| Net cash flow | 0.00 | 0.98 | -0.87 | 0.59 | 0.32 |
| Free cash flow | -0.41 | 0.99 | 6.26 | -3.22 | -19.97 |
| CFO / operating profit | 195% | 196% | 122% | -22% | -231% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Ravelcare Ltd operating ratios
| Per year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | -466.67% | 154.55% | 234.01% | 89.33% | 30.49% |
| Debtor days | 0.00 | 0.00 | 2.81 | 36.24 | 96.29 |
| Inventory days | 0.00 | 307.37 | 24.18 | 103.98 | 90.21 |
| Days payable | — | 148.88 | 72.55 | 21.22 | 71.81 |
| Cash conversion cycle | 0.00 | 158.49 | -45.55 | 119.00 | 114.69 |
| Working capital days | -166.33 | -87.05 | -31.93 | 49.83 | 118.78 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Ravelcare Ltd shareholding pattern
Promoters held 72.94% at Mar 2026, broadly unchanged since Dec 2025. FIIs 2.57% and DIIs 6.28%.
| % held | Dec 2025 | Mar 2026 |
|---|---|---|
| Promoters | 72.94% | 72.94% |
| FIIs | 3.54% | 2.57% |
| DIIs | 8.14% | 6.28% |
| Government | 0.34% | 0.00% |
| Public | 15.04% | 18.21% |
| No. of shareholders | 470 | 363 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Ravelcare Ltd corporate filings
- Intimation of Trading Window ClosureInsider Trading / SASTlow impact
- Ravelcare Limited concludes 8th Annual General Meeting with unanimous approval of all resolutionsAGM/EGMlow impact
Cruxal's analysis: Ravelcare Limited has successfully concluded its 8th Annual General Meeting held on…
Read the full analysis - Ravelcare Limited concludes 8th Annual General Meeting; focuses on leadership continuityAGM/EGMlow impact
Cruxal's analysis: Ravelcare Limited has successfully concluded its 8th Annual General Meeting held on…
Read the full analysis - Ravelcare Ltd publishes notice for Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Ravelcare Ltd has issued a newspaper publication regarding the notice for its upcoming…
Read the full analysis - Ravelcare Ltd files Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Ravelcare Ltd has filed its Annual Report for the financial year 2025-26. The report…
Read the full analysis - Ravelcare Ltd announces new product launchCompany Updatelow impact
Cruxal's analysis: Ravelcare Ltd has issued a press release regarding the launch of a new product. The…
Read the full analysis - Ravelcare Ltd announces change in registered office addressCompany Updatelow impact
Cruxal's analysis: Ravelcare Ltd has formally notified the exchange regarding a change in its registered…
Read the full analysis - Ravelcare Limited Announces Board Re-appointments and Registered Office ShiftOtherslow impact
Cruxal's analysis: Ravelcare Limited has announced the re-appointment of Mr. Ayush Varma as Managing…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.